53 related articles for article (PubMed ID: 29981375)
1. Posaconazole inhibits dengue virus replication by targeting oxysterol-binding protein.
Meutiawati F; Bezemer B; Strating JRPM; Overheul GJ; Žusinaite E; van Kuppeveld FJM; van Cleef KWR; van Rij RP
Antiviral Res; 2018 Sep; 157():68-79. PubMed ID: 29981375
[TBL] [Abstract][Full Text] [Related]
2. An analogue of the antibiotic teicoplanin prevents flavivirus entry in vitro.
De Burghgraeve T; Kaptein SJ; Ayala-Nunez NV; Mondotte JA; Pastorino B; Printsevskaya SS; de Lamballerie X; Jacobs M; Preobrazhenskaya M; Gamarnik AV; Smit JM; Neyts J
PLoS One; 2012; 7(5):e37244. PubMed ID: 22624001
[TBL] [Abstract][Full Text] [Related]
3. Extract of Scutellaria baicalensis inhibits dengue virus replication.
Zandi K; Lim TH; Rahim NA; Shu MH; Teoh BT; Sam SS; Danlami MB; Tan KK; Abubakar S
BMC Complement Altern Med; 2013 Apr; 13():91. PubMed ID: 23627436
[TBL] [Abstract][Full Text] [Related]
4. Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells.
Farias KJ; Machado PR; da Fonseca BA
ScientificWorldJournal; 2013; 2013():282734. PubMed ID: 23431254
[TBL] [Abstract][Full Text] [Related]
5. The citrus flavanone naringenin impairs dengue virus replication in human cells.
Frabasile S; Koishi AC; Kuczera D; Silveira GF; Verri WA; Duarte Dos Santos CN; Bordignon J
Sci Rep; 2017 Feb; 7():41864. PubMed ID: 28157234
[TBL] [Abstract][Full Text] [Related]
6. A NEW COPPER (II)-IMIDAZOLE DERIVATIVE EFFECTIVELY INHIBITS REPLICATION OF DENV-2 IN VERO CELL.
Sucipto TH; Churrotin S; Setyawati H; Martak F; Mulyatno KC; Amarullah IH; Kotaki T; Kameoka M; Yotopranoto S; Soegijanto AS
Afr J Infect Dis; 2018; 12(1 Suppl):116-119. PubMed ID: 29619441
[TBL] [Abstract][Full Text] [Related]
7. Anti-Dengue: A Machine Learning-Assisted Prediction of Small Molecule Antivirals against Dengue Virus and Implications in Drug Repurposing.
Gautam S; Thakur A; Rajput A; Kumar M
Viruses; 2023 Dec; 16(1):. PubMed ID: 38257744
[TBL] [Abstract][Full Text] [Related]
8. RIG-I Recognizes the 5' Region of Dengue and Zika Virus Genomes.
Chazal M; Beauclair G; Gracias S; Najburg V; Simon-Lorière E; Tangy F; Komarova AV; Jouvenet N
Cell Rep; 2018 Jul; 24(2):320-328. PubMed ID: 29996094
[TBL] [Abstract][Full Text] [Related]
9. An hPSC-Derived Tissue-Resident Macrophage Model Reveals Differential Responses of Macrophages to ZIKV and DENV Infection.
Lang J; Cheng Y; Rolfe A; Hammack C; Vera D; Kyle K; Wang J; Meissner TB; Ren Y; Cowan C; Tang H
Stem Cell Reports; 2018 Aug; 11(2):348-362. PubMed ID: 29983385
[TBL] [Abstract][Full Text] [Related]
10. Phenotypical Screening of an MMV Open Box Library and Identification of Compounds with Antiviral Activity against St. Louis Encephalitis Virus.
Sotorilli GE; Gravina HD; de Carvalho AC; Shimizu JF; Fontoura MA; Melo-Hanchuk TD; Cordeiro AT; Marques RE
Viruses; 2023 Dec; 15(12):. PubMed ID: 38140657
[TBL] [Abstract][Full Text] [Related]
11. Structure-Activity Relationships of Ligand Binding to Oxysterol-Binding Protein (OSBP) and OSBP-Related Protein 4.
Severance ZC; Nuñez JI; Le-McClain AT; Malinky CA; Bensen RC; Fogle RS; Manginelli GW; Sakers SH; Falcon EC; Bui RH; Snead KJ; Bourne CR; Burgett AWG
J Med Chem; 2023 Mar; 66(6):3866-3875. PubMed ID: 36916802
[TBL] [Abstract][Full Text] [Related]
12. Identification of Potent Zika Virus NS5 RNA-Dependent RNA Polymerase Inhibitors Combining Virtual Screening and Biological Assays.
Chen Y; Chi X; Zhang H; Zhang Y; Qiao L; Ding J; Han Y; Lin Y; Jiang J
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768218
[TBL] [Abstract][Full Text] [Related]
13. The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication.
Policastro LR; Dolci I; Godoy AS; Silva Júnior JVJ; Ruiz UEA; Santos IA; Jardim ACG; Samby K; Burrows JN; Wells TNC; Gil LHVG; Oliva G; Fernandes RS
Viruses; 2022 Jun; 14(7):. PubMed ID: 35891332
[TBL] [Abstract][Full Text] [Related]
14. Linking Late Endosomal Cholesterol with Cancer Progression and Anticancer Drug Resistance.
Nguyen MKL; Jose J; Wahba M; Bernaus-Esqué M; Hoy AJ; Enrich C; Rentero C; Grewal T
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806209
[TBL] [Abstract][Full Text] [Related]
15. Antiviral Activity of Approved Antibacterial, Antifungal, Antiprotozoal and Anthelmintic Drugs: Chances for Drug Repurposing for Antiviral Drug Discovery.
Abdulaziz L; Elhadi E; Abdallah EA; Alnoor FA; Yousef BA
J Exp Pharmacol; 2022; 14():97-115. PubMed ID: 35299994
[TBL] [Abstract][Full Text] [Related]
16. Repurposing Antifungals for Host-Directed Antiviral Therapy?
Schloer S; Goretzko J; Rescher U
Pharmaceuticals (Basel); 2022 Feb; 15(2):. PubMed ID: 35215323
[TBL] [Abstract][Full Text] [Related]
17. Role of Lipid Transfer Proteins (LTPs) in the Viral Life Cycle.
Avula K; Singh B; Kumar PV; Syed GH
Front Microbiol; 2021; 12():673509. PubMed ID: 34248884
[TBL] [Abstract][Full Text] [Related]
18. Identification of multipotent drugs for COVID-19 therapeutics with the evaluation of their SARS-CoV2 inhibitory activity.
Kumar S; Singh B; Kumari P; Kumar PV; Agnihotri G; Khan S; Kant Beuria T; Syed GH; Dixit A
Comput Struct Biotechnol J; 2021; 19():1998-2017. PubMed ID: 33841751
[TBL] [Abstract][Full Text] [Related]
19. The antifungal drug isavuconazole inhibits the replication of human cytomegalovirus (HCMV) and acts synergistically with anti-HCMV drugs.
Mercorelli B; Celegato M; Luganini A; Gribaudo G; Lepesheva GI; Loregian A
Antiviral Res; 2021 May; 189():105062. PubMed ID: 33722615
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
